Mbtas Ra 500mg injection - PowerPoint PPT Presentation

About This Presentation
Title:

Mbtas Ra 500mg injection

Description:

Mabtas RA is an anticancer medicine which prevents the growth and spread of cancer cells in the body. – PowerPoint PPT presentation

Number of Views:13

less

Transcript and Presenter's Notes

Title: Mbtas Ra 500mg injection


1
Mabtas RA 500mg injection Rituximab
Millionpharma
  • MILLION HEALTH PHARMACEUTICALS

2
DESCRIPTION
  • Mabtas RA 500mg is an anticancer medicine which
    prevents the growth and spread of cancer cells in
    the body. 
  • Mabtas RA 500mg injection also indicated for the
    treatment of Non- Hodgkins lymphoma or chronic
    lymphocytic and with combination with another
    anticancer drugs like methotrexate is used for
    rheumatoid arthritis symptoms in adult treatment. 

3
INDICATION
  • Mabtas RA 500mg and hyaluronidase human injection
    are given alone or combination with other drugs
    to treat certain types of non-Hodgkin's lymphoma
    and chronic lymphocytic leukemia (cancer start in
    WBC).
  • Mabtas RA 500mg injection is also used with
    methotrexate (Otrexup, Rasuvo, Xatmep, others)
    for the treatment rheumatoid arthritis symptoms
    in adults that have been already treated with
    some type of regimenknown as tumor necrosis
    factor (TNF) inhibitor. 

4
Chronic lymphocytic leukemia
5
MECHANISM OF ACTION
  • Mabtas RA 500mg is a type of class called as
    monoclonal antibody and which is a new type of
    "targeted" cancer treatment and an integral part
    of the body's immune system. 
  • Mabtas RA 500mg injection works by linking to the
    CD20 antigen on normal and malignant B-cells.

6
Brand Mabtas RAIngredients
Rituximab Strength 500mg Manufactured Intas
pharmaceuticals ltdPackage injection
  • PRODUCT DETAILS

7
PHARMACOKINETICS
  • ABSORPTIONNot availableDISTRIBUTIONvolume of
    distribution is 3.1 LMETABOLISMMabtas RA
    500mg metabolized by human antimurine antibody
    production.EXCRETIONnot available
  • The half-life of NHL is 22 days and for RA is
    18.0 days, GPA and microscopic
    polyangiitis is 23 days

8
DOSAGE MANAGEMENT
  • Mabtas RA 500mg injection is recommended to
    administer only through intravenous infusion not
    by IV push or bolus.
  • ADMINISTRTION
  • Take an Mabtas RA 500mg injection amount and
    diluted to final concentration of 1 mg/ml up to 4
    mg/ml as infusion (containing either 0.9 Nacl or
    5 dextrose in water). Invert gently the bag and
    mix the solution. Dispose unused drug left in
    vial.

9
PRECAUTIONS
  • Allergic condition against Mabtas RA 500mg or any
    other medication informs your doctor.
  • While using Mabtas RA 500mg injection do not take
    any vaccination or immunization without taking
    advice from doctors.
  • It is unknown whether Mabtas RA 500mg
    injection passes into breast milk, avoid
    breast-feed while on Mabtas RA 500mg treatment.

10
SIDE EFFECTS
  • Common effectsfever and chills (flu like
    symptoms)
  • Less common side effectsWeakness nausea
    headache cough dyspnea pharyngitis

11
DRUG INTERACTION
  • Mabtas RA 500mg injection drug interaction has
    limited data is available at present.Combination
    with fludarabine or cyclophosphamide has no
    effects in pharmacokinetics in CLL
    patients.Combination with methotrexate had no
    effects in pharmacokinetics.

12
CONTRAINDICATIONS
  • Hypersensitivity or murine proteins.Active
    severe infections in rheumatoid
    arthritisUncontrolled cardiac disease.

13
PREGNANCY
  • Category C animal studies reproduction shown an
    adverse effect on the fetus. The drug has no
    enoughand well controlled studies in humans,
    using in pregnant women benefits by warrant use
    of the drug.

14
LACTATION
  • Mabtas RA 500mg excreted into human milk is
    unknown. Due to the drug belongs to large protein
    molecule, no information is available. Women
    should not breast feed during Mabtas RA 500mg
    treatment and 12 months following last dose.

15
STORAGE
  • Store at 20C 30C Use the drug before
    expiry date Protected from direct sunlight Do
    not freeze or shake. Keep away from the
    childrens Discard the unused drug by asking
    the advice from doctor or pharmacist.

16
MISSED DOSE
  • Mabtas RA 500mg injection excreted into human
    milk is unknown. Due to the drug belongs to large
    protein molecule, no information is available.
    Women should not breast feed during Mabtas RA
    500mg treatment and 12 months following last dose.

17
OVERDOSAGE
  • If the patients had high dose of Mabtas RA
    500mg then seek immediately to the emergency
    department or poison control help line. Please
    consult the doctor for further clarification.

18
CONTACT US 
  • PHONE NO
  • 91-9940472902
  • EMAIL millionhealthpharmaceuticals_at_gmail.com
  • WEBSITE URL https//millionpharma.com/mabtas-
    ra-500mg.php
Write a Comment
User Comments (0)
About PowerShow.com